Thank you for joining us at ATC 2026. You can view our ATC symposium, abstracts, posters and additional product information below.
This symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC.
Symposium
Click the YouTube ‘Settings’ icon in the video window above 
to select your preferred caption language.
The Next Era of Machine Perfusion: From Evidence to Adoption in Clinical Practice
Location: 156 ABC at the Thomas M. Menino Convention & Exhibition Center Date/Time: June 22, 2026, 7:00 am – 8:00 am
Session Description:
This session will define the next phase of machine perfusion in liver transplantation by connecting clinical evidence with real-world implementation in the early U.S. post-commercialization setting. The program will begin with the Bridge to HOPE trial, a pivotal study evaluating HOPE in liver transplantation, and its implications for current practice, followed by an updated perspective on the clinical and mechanistic rationale for HOPE. It will then explore how viability assessment during hypothermia is evolving from descriptive observation to objective decision making, and conclude with a discussion of the economic and operational realities of implementing perfusion at scale, including workflow integration, resource utilization, and long-term sustainability in the HOPE era.
Agenda
Welcome & Framing: Why HOPE Matters Now
Moderator: Roberto Hernandez- Alejandro, MD, FACS, FRCSC, University of Rochester Medical Center
From Trial to Practice: What HOPE Changes in 2026
Speaker: David Foley, MD, University of Wisconsin
Click the YouTube ‘Settings’ icon in the video window above to select your preferred caption language.
Beyond Traditional Biomarkers: Viability Assessment During Hypothermic Perfusion
Speaker: Andrea Schlegel, MD, MBA, Cleveland Clinic
Click the YouTube ‘Settings’ icon in the video window above to select your preferred caption language.
From Adoption to Sustainability in the HOPE Era
Speaker: Ian Jamieson, MBA, MHA, Duke Transplant Center
Click the YouTube ‘Settings’ icon in the video window above to select your preferred caption language.
Panel Discussion: The Next Phase of Adoption
Plenary Presentation
View Abstract View Poster
Comparison of Hypothermic Oxygenated and Normothermic Machine Perfusion of Human Small Intestine for Transplantation
Session Title: Monday Plenary Session
Location: Ballroom | Date/Time: Mon, June 22, 8:15 am – 9:15 am
Presenter: Koki Takase, MD, Cleveland Clinic
Oral Presentations
View Abstract View Poster
HOPE for Human Uterus Transplantation: Improved Preservation and Viability Assessment for Enhanced Donor Utilization
Session Title: Emerging Discoveries Oral Abstract Session – VCA
Location: 254AB, Level 2
Date/Time: Sun, June 21, 3:45 pm – 4:45 pm
Presenter: Keyue Sun, MD, Cleveland Clinic
View Abstract View Poster
Donor Serum FMN Reflects Mitochondrial Injury and Predicts Outcomes After Liver Transplantation: A Metabolic Donor Signature of Graft Quality
Session Title: Emerging Discoveries Oral Abstract Session – Liver: Expanding the Donor Pool -1
Location: 210A, Level 2
Date/Time: Sun, June 21, 3:45 pm – 4:45 pm
Presenter: F. Selin Yildirim, MD, Cleveland Clinic
Invited Presentations
Normothermic vs. hypothermic machine perfusion – is one superior to the other?
Session Title: Interactive Symposium – Advanced Liver Perfusion: Successes, Setbacks, and Lessons Learned
Location: 204AB, Level 2
Date/Time: Tue, June 23, 7 am – 8 am
Presenter: Andrea Schlegel, MD, Cleveland Clinic
Poster Presentations
View Abstract View Poster
Extended Hypothermic Machine Perfusion (HOPE) – A Safe Method to Facilitate Prolonged Ex-Situ Preservation of DCD Liver Grafts
Session Title: Liver: Expanding the Donor Pool
Location: Exhibit Hall, Abstract A 175 | Date/Time: Sat, June 20, 5:45 p.m. – 6:45 p.m.
Presenter: Janske Reiling, MD, University Hospital Birmingham
